Pharmacoeconomical analysis of gatifloxacin and levofloxacin in treatment of urinary tract infection
LU Mia
Abstract
LU Mia
Abstract
Objective To analyze the cost-effect of gatifloxacin and levofloxacin in treatment of urinary tract infection.Methods 80 cases with urinary infection were randomly divided into 2 groups,in which they were treated with gatifloxacin and levofloxacin,respectively.The cost-effect in two groups was analyzed and compared with each other by pharmacoeconomical method.Results There was no significant difference in therapeutic effect between two groups(P0.05),such as effective rate of 92.5% and95.0%,bacterial clearance rates of 92.6% and 85.7% and undesired event rates of 3.61% and 4.22% in gatifloxacin group and levofloxacin group.However,there was significant difference in cost-effect ratio between two group,83.0 and 45.5 respectively in gatifloxacin group and levofloxacin group(P0.05).Conclusion Levofloxacin has cost-effect advantage over gatifloxacin in the treatment of urinary tract infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To analyze the cost-effect of gatifloxacin and levofloxacin in treatment of urinary tract infection.Methods 80 cases with urinary infection were randomly divided into 2 groups,in which they were treated with gatifloxacin and levofloxacin,respectively.The cost-effect in two groups was analyzed and compared with each other by pharmacoeconomical method.Results There was no significant difference in therapeutic effect between two groups(P0.05),such as effective rate of 92.5% and95.0%,bacterial clearance rates of 92.6% and 85.7% and undesired event rates of 3.61% and 4.22% in gatifloxacin group and levofloxacin group.However,there was significant difference in cost-effect ratio between two group,83.0 and 45.5 respectively in gatifloxacin group and levofloxacin group(P0.05).Conclusion Levofloxacin has cost-effect advantage over gatifloxacin in the treatment of urinary tract infection.
Key concepts: Gatifloxacin, Levofloxacin, Urinary system, Medicine, Significant difference, Internal medicine, Chemistry, Antibiotics